Literature DB >> 2493986

Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.

T Sugimoto1, Y Horii, T Hino, J T Kemshead, H Kuroda, T Sawada, H Morioka, J Imanishi, H Inoko.   

Abstract

Five neuroblastoma cell lines have been examined for the induction of HLA class II antigens by a recombinant gamma-interferon. The expression of HLA-DR and -DP was induced on up to 80% of cells in two of five neuroblastoma cell lines examined (KP-N-SI and KP-N-RT). Low expression of HLA-DR and -DP was induced on the SK-N-DZ line in the presence of recombinant gamma-interferon for 10 days. In contrast HLA-DQ was not induced on any of five neuroblastoma cell lines studied. HLA-DR and -DP antigen induction was reversible, falling to nondetectable levels when interferon was removed from the culture medium. The reinduction of interferon to the culture medium again induced HLA-DR and -DP antigen expression in a fashion similar to that originally observed. These results were confirmed by Northern blot analysis using a probe to HLA-DR alpha mRNA. Recombinant interferon appears to induce HLA class II expression at the level of gene transcription or posttranscription. The results also indicate that HLA-DR, -DP, and -DQ antigens are independently regulated. Treatment of neuroblastoma cell lines with gamma-interferon results in the induction of a differentiated phenotype. Although the cytokine gamma-interferon induces neurofilament expression in some of the cell lines, this was not the case for all lines studied. Thus no correlation could be established between the morphological differentiation and either HLA class II or neurofilament expression. In addition, no correlation between response to recombinant interferon and N-myc amplification was noted. The biological significance of HLA class II expression on neuroblastoma cell lines by gamma-interferon may be related to the differentiation stage of neuroblastoma cells or may enable gamma-interferon-treated neuroblastoma cells to be recognized by cytotoxic T-cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493986

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma.

Authors:  Kohei Otake; Keiichi Uchida; Kouji Tanaka; Yuhki Koike; Mikihiro Inoue; Kohei Matsushita; Motoko Ueeda; Kiyoshi Hashimoto; Takahito Kitajima; Yoshihiro Komada; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

2.  Induction of ICAM-1 on human neural cells and mechanisms of neutrophil-mediated injury.

Authors:  H H Birdsall
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

3.  Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.

Authors:  J Gopas; D Itzhaky; Y Segev; S Salzberg; B Trink; N Isakov; B Rager-Zisman
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 4.  Engineering universal cells that evade immune detection.

Authors:  Robert Lanza; David W Russell; Andras Nagy
Journal:  Nat Rev Immunol       Date:  2019-08-15       Impact factor: 53.106

5.  Increased expression of trk proto-oncogene by gamma-interferon in human neuroblastoma cell lines.

Authors:  A Shikata; T Sugimoto; H Hosoi; Y Sotozono; T Shikata; T Sawada; L F Parada
Journal:  Jpn J Cancer Res       Date:  1994-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.